EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influence of epilepsy and antiepileptic drug intake in patients suffering from aneurysmal subarachnoid hemorrhage on outcome

Tim Lampmann, Harun Asoglu, Haitham Alenezi, Mohammed Jaber, Bettina Otto, Mohammed Banat, Erdem Güresir, Hartmut Vatter, Motaz Hamed

Brain and Spine · 2026 · 6 · 105924

DOI: 10.1016/j.bas.2025.105924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Spine, 2026. Verfasst von Tim Lampmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Hospital Bonn, Venusberg Campus 1, Bonn, 53127, Germany. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Many patients suffering from aneurysmal subarachnoid hemorrhage (SAH) develop epileptic seizures. The recent guidelines do not recommend routine administration of antiepileptic drugs (AED). Research question: We performed a retrospective single-center study to analyze the effect of AEDs on the outcome in patients suffering from epilepsy after SAH.

Methods

752 patients with SAH treated between 01/2006 and 12/2020 were analyzed. Patients were divided into good-grade (WFNS grades I-II) versus poor-grade (WFNS grades III-V) on admission. Data of patients' history as well as clinical course were collected. Outcome according to the modified Rankin scale (mRS) score was assessed at 6 months after ictus. Outcome was dichotomized into favorable (mRS 0-2) and unfavorable (mRS 3-6). Univariate and multivariate analyses were performed.

Results

346 (46.0 %) patients suffered from poor-grade SAH and 366 (48.7 %) patients achieved unfavorable outcome. 202 (26.9 %) patients suffered from seizures after SAH and 136 (18.1 %) had to be treated with antiepileptic drugs (AEDs) for more than a week. Epilepsy and AED intake after 3 months was more often in patients with unfavorable outcome (18.9 % vs. 8.3 %; p 50 years' (p = 0.001, OR 2.7, 95 % CI 1.5-4.8, 'aneurysm size >10 mm' (p = 0.018, OR 2.2, 95 % CI 1.1-4.1), 'hydrocephalus' (p = 0.002, OR 2.6, 95 % CI 1.4-4.7), 'delayed cerebral ischemia' (p = 0.002, OR 5.0, 95 % CI 2.3-10.9) and 'epilepsy within 3 months' (p = 0.002, OR 5.9, 95 % CI 1.9-18.3) were predictors for unfavorable outcome, whereas 'AED intake after 6 months' (p = 0.037, OR 0.35, 95 % CI 0.13-0.94) was predictor for favorable outcome.

Conclusions

Manifestation of epilepsy in patients suffering from SAH deteriorates outcome. Continued AED intake in SAH patients who developed epileptic seizures should be advised.

Schlagwörter

Stichwörter der Autor:innen

AEDSAHSeizure

Autor:innen und Institutionen

  • Department of Neurosurgery, University Hospital Bonn, Venusberg Campus 1, Bonn, 53127, Germany.
  • Neurological Rehabilitation Center Godeshöhe, Waldstraße 2-10, Bonn, 53177, Germany.

Zitieren

APA

Lampmann, T., Asoglu, H., Alenezi, H., Jaber, M., Otto, B., Banat, M., Güresir, E., Vatter, H., & Hamed, M. (2026). Influence of epilepsy and antiepileptic drug intake in patients suffering from aneurysmal subarachnoid hemorrhage on outcome. Brain and Spine, 6, 105924. https://doi.org/10.1016/j.bas.2025.105924

Vancouver

Lampmann T, Asoglu H, Alenezi H, Jaber M, Otto B, Banat M, et al. Influence of epilepsy and antiepileptic drug intake in patients suffering from aneurysmal subarachnoid hemorrhage on outcome. Brain and Spine. 2026;6:105924. doi:10.1016/j.bas.2025.105924

BibTeX
@article{Lampmann2026,
  author = {Lampmann, Tim and Asoglu, Harun and Alenezi, Haitham and Jaber, Mohammed and Otto, Bettina and Banat, Mohammed and Güresir, Erdem and Vatter, Hartmut and Hamed, Motaz},
  title = {Influence of epilepsy and antiepileptic drug intake in patients suffering from aneurysmal subarachnoid hemorrhage on outcome},
  journal = {Brain and Spine},
  year = {2026},
  volume = {6},
  pages = {105924},
  doi = {10.1016/j.bas.2025.105924}
}
Kostenlos starten →